Conestat alfa (ruconest): first recombinant c1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema.

Abstract

Conestat alfa (Ruconest): first recombinant C1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema. 

Topics

Cite this paper

@article{Cruz2015ConestatA, title={Conestat alfa (ruconest): first recombinant c1 esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema.}, author={Martin Paspe Cruz}, journal={P & T : a peer-reviewed journal for formulary management}, year={2015}, volume={40 2}, pages={109-14} }